Megan E. Cull
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Megan E. Cull has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Louise M. Winn
Department of Biomedical and Molecular Sciences Queen's University at Kingston Kingston Canada
3 shared publications - Lauren T. L. Brown
Department of Biomedical and Molecular Sciences Queen's University at Kingston Kingston Canada
2 shared publications Perri M. Grant
2 shared publications- Caitlyn I. Kirkpatrick1 shared publication
Delaine Pereira
Department of Biomedical and Molecular Sciences Queen's University at Kingston Kingston Canada
1 shared publicationHolly Mackay
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Reproductive Toxicology
- Vol. 146
The maternal–placental–fetal liver axis: A mechanistic framework for understanding benzene developmental hematotoxicity
- 19 October 2026
- Published by Elsevier in Reproductive Toxicology
- Vol. 146
Open AccessThe maternal–placental–fetal liver axis: A mechanistic framework for understanding benzene developmental hematotoxicity
- Open Access
- 15 April 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (4) , e70044
Mind the Litter: The Critical Role of Intralitter Variables in Reproductive and Developmental Toxicology Research
Background: Animal models remain essential for understanding developmental toxicology, providing insights into how in utero exposures affect fetal and placental outcomes. Litter‐bearing species are widely used due to their efficiency and reproducibility, but conventional approaches often summarize outcomes at the litter level, masking meaningful within‐litter variability. Aim: This review highlights three primary sources of intralitter variability: litter size, uterine implantation location, and fetal sex, and their influence on fetal and placental growth, mortality, and malformations. Discussion: Larger litters restrict fetal growth through intrauterine competition, while toxicant‐induced changes in litter size can obscure or exaggerate effects. Implantation location within uterine horns influences perfusion, nutrient delivery, and local exposure to hormones or toxicants, introducing spatially dependent vulnerability. Fetal sex further modifies responses, as male and female fetuses and placentas differ in growth trajectories, gene expression, and adaptive capacity, leading to sex‐specific susceptibility to toxicants. Conclusion: Ignoring these sources of variability risks overlooking subtle effects and vulnerable subpopulations, misinterpreting outcomes, and reducing the translational value of animal studies. We argue that incorporating intralitter variables into experimental design and statistical analyses enhances the accuracy, reproducibility, and interpretability of developmental toxicology research. By refining the use of animal models in line with the 3Rs framework, researchers can maximize the information gained per pregnancy and improve risk assessment for human maternal‐fetal health.
- 15 April 2026
- Published by Wiley in Birth Defects Research
- Vol. 118 (4) , e70044
Open AccessMind the Litter: The Critical Role of Intralitter Variables in Reproductive and Developmental Toxicology Research
Background: Animal models remain essential for understanding developmental toxicology, providing insights into how in utero exposures affect fetal and placental outcomes. Litter‐bearing species are widely used due to their efficiency and reproducibility, but conventional approaches often summarize outcomes at the litter level, masking meaningful within‐litter variability. Aim: This review highlights three primary sources of intralitter variability: litter size, uterine implantation location, and fetal sex, and their influence on fetal and placental growth, mortality, and malformations. Discussion: Larger litters restrict fetal growth through intrauterine competition, while toxicant‐induced changes in litter size can obscure or exaggerate effects. Implantation location within uterine horns influences perfusion, nutrient delivery, and local exposure to hormones or toxicants, introducing spatially dependent vulnerability. Fetal sex further modifies responses, as male and female fetuses and placentas differ in growth trajectories, gene expression, and adaptive capacity, leading to sex‐specific susceptibility to toxicants. Conclusion: Ignoring these sources of variability risks overlooking subtle effects and vulnerable subpopulations, misinterpreting outcomes, and reducing the translational value of animal studies. We argue that incorporating intralitter variables into experimental design and statistical analyses enhances the accuracy, reproducibility, and interpretability of developmental toxicology research. By refining the use of animal models in line with the 3Rs framework, researchers can maximize the information gained per pregnancy and improve risk assessment for human maternal‐fetal health.
- Open Access
- 21 July 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (12) , 2624-2640
Intralitter Variability Influences the Developmental Impact of Valproic Acid Exposure in CD‐1 Mice
Valproic acid (VPA) is an antiepileptic and mood‐stabilizing drug that causes teratogenic effects, including neural tube defects (NTDs), when taken during pregnancy. Although animal models are widely used to study VPA teratogenicity, most rely on litter means, which overlook variability within the litter. In litter‐bearing species like mice, fetal development can vary by sex, uterine horn location, and intrauterine position. This study examined whether these intralitter variables affect fetal and placental outcomes following VPA exposure. Pregnant CD‐1 mice received a subcutaneous injection of saline (vehicle control), 400 mg/kg, or 600 mg/kg VPA on gestational day (GD) 9 and were euthanized on GD 18. Fetuses and placentas were collected, weighed, and stratified by exposure, NTD status, sex, uterine horn location, and intrauterine position. Fetal and placental weights were normalized to maternal weight gain and live litter size or the number of live fetuses in each uterine horn. VPA exposure produced a clear dose‐dependent effect, with 600 mg/kg significantly increasing postimplantation losses and NTD frequency. These effects were further influenced by intralitter variables, particularly sex and uterine horn location. Fetal weight increased at 400 mg/kg VPA but was unchanged at 600 mg/kg, while placental weight decreased and placental efficiency increased at both doses, suggesting possible compensatory adaptations. At 600 mg/kg VPA, sex differences in placental weight and efficiency were lost, and fetuses in the left uterine horn were significantly lighter than those in the right, indicating location‐dependent susceptibility. Intrauterine position did not significantly affect outcomes. These findings demonstrate that intralitter variables influence fetal and placental responses to VPA and underscore the need to account for these factors to improve the translational relevance of developmental toxicology studies.
- 21 July 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (12) , 2624-2640
Open AccessIntralitter Variability Influences the Developmental Impact of Valproic Acid Exposure in CD‐1 Mice
Valproic acid (VPA) is an antiepileptic and mood‐stabilizing drug that causes teratogenic effects, including neural tube defects (NTDs), when taken during pregnancy. Although animal models are widely used to study VPA teratogenicity, most rely on litter means, which overlook variability within the litter. In litter‐bearing species like mice, fetal development can vary by sex, uterine horn location, and intrauterine position. This study examined whether these intralitter variables affect fetal and placental outcomes following VPA exposure. Pregnant CD‐1 mice received a subcutaneous injection of saline (vehicle control), 400 mg/kg, or 600 mg/kg VPA on gestational day (GD) 9 and were euthanized on GD 18. Fetuses and placentas were collected, weighed, and stratified by exposure, NTD status, sex, uterine horn location, and intrauterine position. Fetal and placental weights were normalized to maternal weight gain and live litter size or the number of live fetuses in each uterine horn. VPA exposure produced a clear dose‐dependent effect, with 600 mg/kg significantly increasing postimplantation losses and NTD frequency. These effects were further influenced by intralitter variables, particularly sex and uterine horn location. Fetal weight increased at 400 mg/kg VPA but was unchanged at 600 mg/kg, while placental weight decreased and placental efficiency increased at both doses, suggesting possible compensatory adaptations. At 600 mg/kg VPA, sex differences in placental weight and efficiency were lost, and fetuses in the left uterine horn were significantly lighter than those in the right, indicating location‐dependent susceptibility. Intrauterine position did not significantly affect outcomes. These findings demonstrate that intralitter variables influence fetal and placental responses to VPA and underscore the need to account for these factors to improve the translational relevance of developmental toxicology studies.